Latest & greatest articles for anxiety

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on anxiety or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on anxiety and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Anxiety

Anxiety is the subjectively feelings of dread over anticipated events and it is different from fear. Clinical anxiety is a group of mental disorders with generalised anxiety disorder (GAD) being the most common (approximately 22% of primary care attendances for anxiety are classed as GAD). Overall, there is a lifetime prevalence rate of 4-7%. Anxiety can be caused by a number of factors typically classified as environmental surroundings and genetic.

In the past few decades anxiety research has significantly increased. In 2000 there were approximately 430 trials looking at anxiety and by 2015 to over 1,000. This has allowed medical professionals to develop and improve accurate diagnosis and treatments in patients suffering from the condition.

Anxiety is normal in uncomfortable environments or stressful situations. However, some individuals experience intense and persistent amounts of anxiety which needs to be kept under control. Treatments include pharmaceuticals such as SSRIs, benzodiazepines, pregabalin and gabapentin. Other therapies include CBT, acceptance and commitment therapy, and motivational interviewing.

Trip has all the latest evidence relating to treatments for anxiety, this includes systematic reviews, clinical guidelines, controlled trials, evidence-based synopses, case reports and clinical Q&As.

Top results for anxiety

461. The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review.

The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review. The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review. The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review. Rose C (...) , Wallace L, Dickson R, Ayres J, Lehman R, Searle Y, Burge P S Authors' objectives To investigate whether psychological interventions are effective methods of reducing anxiety and panic in patients with chronic obstructive pulmonary disease (COPD). Searching MEDLINE, PsycLIT, CINAHL, ASSIA, the National Research Register, ISI (via BIDS), EMBASE, ClinPSYC, the Cochrane Controlled Trials Register, Dissertation Abstracts Online, Networked Digital Library of Theses and Dissertations, and the British Index

DARE.2002

462. A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety

A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety Kaltenthaler E, Shackley P, Stevens K, Beverley C, Parry G, Chilcott J Authors' objectives To assess the effectiveness of computer-based cognitive (...) behaviour therapy (CCBT) for treating anxiety, depression and phobias, and to compare the cost-effectiveness of CCBT with cognitive behaviour therapy (CBT) by conventional methods and treatment as usual (TAU). Searching Seventeen bibliographic databases, including grey literature and current research, were searched from 1966 to September 2001 for English and non-English language studies. The authors reported the individual databases and search terms, and also listed the health services research-related resources

DARE.2002

463. Does religious psychotherapy improve anxiety and depression in religious adults: a review of randomized controlled studies

Does religious psychotherapy improve anxiety and depression in religious adults: a review of randomized controlled studies Does religious psychotherapy improve anxiety and depression in religious adults: a review of randomized controlled studies Does religious psychotherapy improve anxiety and depression in religious adults: a review of randomized controlled studies Berry D Authors' objectives To review the randomised evidence for the use of religious psychotherapy in adults with anxiety (...) mechanisms. Whether the therapist was religious or nonreligious was also a randomised condition in one study. Participants included in the review Studies with a population comprising adults with anxiety or depression disorders were eligible for inclusion. The patients included in the review had diagnoses of generalised anxiety disorder, dysthymic disorder, major depressive disorder and nonpsychotic, nonbipolar depression. Outcomes assessed in the review Studies assessing any outcome were eligible

DARE.2002

464. A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety

A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety Journals Library An error has occurred in processing the XML document An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from

NIHR HTA programme2002

465. Kava extract for treating anxiety.

Kava extract for treating anxiety. BACKGROUND: Synthetic anxiolytic drugs are effective for anxiety, but are often burdened with adverse events. Constraints on resources and time often render treatments such as psychological interventions impracticable. Thus, an effective and safe oral medication would be of considerable interest and a welcome addition to the therapeutic repertoire. OBJECTIVES: To systematically review the evidence from rigorous clinical trials assessing the efficacy and safety (...) of kava extract versus placebo for the treatment of anxiety. SEARCH STRATEGY: Publications describing randomised controlled trials (RCTs) of kava extract for anxiety were sought through Medline, Embase, Biosis, AMED, CISCOM and the Cochrane Library (all from their respective inception to June 1998). The search terms used were kava, kawa, kavain, Piper methysticum and Rauschpfeffer (German common name for Piper methysticum). Manufacturers of kava preparations and experts on the subject were contacted

Cochrane2002

466. Physical activity dose-response effects on outcomes of depression and anxiety

Physical activity dose-response effects on outcomes of depression and anxiety Physical activity dose-response effects on outcomes of depression and anxiety Physical activity dose-response effects on outcomes of depression and anxiety Dunn A L, Trivedi M H, O'Neal H A Authors' objectives To examine the scientific evidence for a dose-response relationship between physical activity and depressive and anxiety disorders. Searching MEDLINE, PsycLIT and the Internet were searched (dates of searches (...) -experimental studies and randomised controlled trials (RCTs). Specific interventions included in the review Studies that measured the effects of any type of physical activity (occupational or leisure-time) on anxiety and depression were eligible for inclusion. The majority of studies did not specify the type of physical activity. Participants included in the review Studies that included participants with symptoms of anxiety or depression according to the Diagnostic and Statistical Manual of Mental

DARE.2001

467. The clinical and cost-effectiveness of self-help treatments for anxiety and depressive disorders in primary care: a systematic review

The clinical and cost-effectiveness of self-help treatments for anxiety and depressive disorders in primary care: a systematic review The clinical and cost-effectiveness of self-help treatments for anxiety and depressive disorders in primary care: a systematic review The clinical and cost-effectiveness of self-help treatments for anxiety and depressive disorders in primary care: a systematic review Bower P, Richards D, Lovell K Authors' objectives To determine the clinical and cost (...) -effectiveness of self-help treatments for anxiety and depression in primary care by conducting a systematic review of randomised and non-randomised trials of self-help interventions for patients with anxiety and depression in primary care. Searching Searches of PsycINFO (from 1967 to 1999), MEDLINE (from 1966 to 1999), EMBASE (from 1980 to 1999), CINAHL (from 1982 to 1999), the Cochrane Controlled Trials Register (Issue 2, 1999), the Counsel.lit database of the Counselling in Primary Care Trust

DARE.2001

468. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group.

Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. 11323729 2001 04 12 2001 05 10 2013 11 21 0028-4793 344 17 2001 Apr 26 The New England journal of medicine N. Engl. J. Med. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. 1279-85 Drugs that selectively inhibit serotonin reuptake are effective (...) treatments for adults with mood and anxiety disorders, but limited data are available on the safety and efficacy of serotonin-reuptake inhibitors in children with anxiety disorders. We studied 128 children who were 6 to 17 years of age; who met the criteria for social phobia, separation anxiety disorder, or generalized anxiety disorder; and who had received psychological treatment for three weeks without improvement. The children were randomly assigned to receive fluvoxamine (at a maximum of 300 mg per

NEJM2001

469. Kava extract for treating anxiety.

Kava extract for treating anxiety. BACKGROUND: Synthetic anxiolytic drugs are effective for anxiety, but they are burdened with adverse events. Constraints on resources and time often render treatments such as psychological interventions impracticable. Thus, an effective and safe oral medication would be of considerable interest and a welcome addition to the therapeutic repertoire. OBJECTIVES: To systematically review the evidence regarding the efficacy and safety of kava extract (...) for the symptomatic treatment of anxiety. SEARCH STRATEGY: Computerized literature searches were performed in the databases Medline, Embase, Biosis, AMED, CISCOM and the Cochrane Library (all from their respective inception to June 1998). The search terms used were kava, kawa, kavain, Piper methysticum and Rauschpfeffer (German common name for Piper methysticum). Manufacturers of kava preparations and experts on the subject were contacted and asked to contribute published and unpublished material. In addition

Cochrane2001

470. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis

Efficacy of kava extract for treating anxiety: systematic review and meta-analysis Efficacy of kava extract for treating anxiety: systematic review and meta-analysis Efficacy of kava extract for treating anxiety: systematic review and meta-analysis Pittler M H, Ernst E Authors' objectives To assess the efficacy of kava extract for treating anxiety. Searching Computerised searches were conducted of the following databases from their respective inceptions to June 1998: MEDLINE; EMBASE; BIOSIS (...) hospital, and general hospital. One study in which kava extract was combined with benzodiazepines and studies using kavain were excluded. Participants included in the review The following groups of patients with anxiety were included: outpatients with anxiety of nonpsychiatric origin including those with anxiety according to American Psychiatric Association DSM-III-R criteria; females; anxiety diagnosed on State Trait Anxiety Inventory; preoperative patients; and female patients between taking tissue

DARE.2000

471. Autogenic training for stress and anxiety: a systematic review

Autogenic training for stress and anxiety: a systematic review Autogenic training for stress and anxiety: a systematic review Autogenic training for stress and anxiety: a systematic review Kanji N, Ernst E Authors' objectives To evaluate all controlled trials of autogenic training (AT) as a means of reducing stress and anxiety levels in humans. Searching The authors searched MEDLINE from 1969 to 1997, CISCOM in April 1998, PsycLIT from 1974 to March 1998, and CINAHL from 1982 to January 1998 (...) , using the following search terms: 'autogenic training', 'autogenics', 'stress' and 'anxiety'. Reference lists of retrieved reports, published review articles, various textbooks, and Luthe's extensive collection of papers held by The British Autogenic Society Library were also examined manually. Studies published in the English language, and one study published in Italian, were included. Authors were not contacted for additional information. No abstracts, review articles or unpublished articles were

DARE.2000

472. Long-term pharmacological treatment of generalized anxiety disorder

Long-term pharmacological treatment of generalized anxiety disorder Long-term pharmacological treatment of generalized anxiety disorder Long-term pharmacological treatment of generalized anxiety disorder Mahe V, Balogh A Authors' objectives To identify any pharmacological treatment that has been proven to benefit patients with generalised anxiety disorder (GAD). Searching MEDLINE, BIOSIS Previews and EMBASE (1963 to 1998) were searched for trials using the terms, 'generalized anxiety disorder (...) ', 'anxiety neurosis' or 'anxiety'. Study selection Study designs of evaluations included in the review Clinical trials. Seven out of fourteen were double blind, three were placebo controlled and six were open label trials. Studies had to be of at least two months duration and ranged from 2.5 months to 12 months. Specific interventions included in the review Any pharmacological interventions. Interventions evaluated in the included studies were kava-kava (70mg); clobazam (10mg); diazepam (5mg-33mg

DARE.2000

473. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care

Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care Randomised controlled trial of non-directive counselling, cognitive (...) -behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care King M, Sibbald B, Ward E, Bower P, Lloyd M, Gabbay M, Byford S Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation King M, Sibbald B, Ward E, Bower P, Lloyd M, Gabbay M, Byford S. Randomised controlled trial of non-directive

Health Technology Assessment (HTA) Database.2000

474. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care

Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care Journals Library An error has occurred in processing the XML document An error

NIHR HTA programme2000

475. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.

Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial. 10865302 2000 07 11 2000 07 11 2016 10 17 0098-7484 283 23 2000 Jun 21 JAMA JAMA Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial. 3082-8 Generalized anxiety disorder (GAD) is a chronic disorder that is associated with debilitating psychic (...) from baseline in the Hamilton Rating Scale for Anxiety (HAM-A) total score, the HAM-A psychic anxiety factor score, and the Clinical Global Impressions (CGI) scale Severity of Illness and Global Improvement scores, compared by intervention group. During weeks 6 through 28, response rates in the venlafaxine XR group were 69% or higher compared with rates of 42% to 46% in the placebo group (P<.001). By an evaluable-patient analysis, venlafaxine XR compared with placebo significantly improved anxiety

JAMA2000

476. Premedication for anxiety in adult day surgery.

Premedication for anxiety in adult day surgery. BACKGROUND: Surgery is increasingly performed on a day-case basis. Many patients are anxious pre-operatively and might benefit from pharmacological anxiolysis. Drugs are sometimes not used, however, for fear of delaying discharge from hospital. OBJECTIVES: To asses the effect of anxiolytic premedication on time to discharge in adult patients undergoing day case surgery under general anaesthesia. SEARCH STRATEGY: Trials were identified (...) by computerised searches of the Cochrane Controlled Trials Register, MEDLINE, EMBASE, by checking the reference lists of trials and review articles, by hand-searching three main anaesthesia journals and by contacting five researchers active in the field and the Product Information departments of the manufacturers of five commonly used premedicants. SELECTION CRITERIA: All randomised controlled trials comparing an anxiolytic drug(s) with placebo before general anaesthesia in adult day case surgical patients

Cochrane2000

477. Premedication for anxiety in adult day surgery.

Premedication for anxiety in adult day surgery. BACKGROUND: Surgery is increasingly performed on a day-case basis. Many patients are anxious pre-operatively and might benefit from pharmacological anxiolysis. Drugs are sometimes not used, however, for fear of delaying discharge from hospital. OBJECTIVES: To asses the effect of anxiolytic premedication on time to discharge in adult patients undergoing day case surgery under general anaesthesia. SEARCH STRATEGY: Trials were identified (...) by computerised searches of the Cochrane Controlled Trials Register, MEDLINE, EMBASE, by checking the reference lists of trials and review articles, by hand-searching three main anaesthesia journals and by contacting five researchers active in the field and the Product Information departments of the manufacturers of five commonly used premedicants. SELECTION CRITERIA: All randomised controlled trials comparing an anxiolytic drug(s) with placebo before general anaesthesia in adult day case surgical patients

Cochrane2000

478. The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta analyses

The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta analyses The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta analyses The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta analyses Sheard T, Maguire P Authors' objectives To conduct 2 meta-analyses of trials of psychological interventions in patients with cancer, the first using (...) anxiety and the second depression as a main outcome measure. Searching MEDLINE, PsycLIT and the Social Sciences Citation Index were searched using the keywords: cancer, counselling, psychotherapy, psychological therapy, group support/therapy, relaxation, imagery and visualization. Citations in identified papers and reviews, ASLIB Index to Theses (keywords: cancer, counselling and psychotherapy), and Comprehensive Dissertation Abstracts: Psychology (keyword: cancer) were manually searched. Only trials

DARE.1999

479. Effects of video information on precolonoscopy anxiety and knowledge: a randomised trial.

Effects of video information on precolonoscopy anxiety and knowledge: a randomised trial. 10636368 2000 01 27 2000 01 27 2015 06 16 0140-6736 354 9195 1999 Dec 11 Lancet (London, England) Lancet Effects of video information on precolonoscopy anxiety and knowledge: a randomised trial. 2032-5 The provision of information before medical or surgical procedures should improve knowledge and allay anxiety about the pending procedure. This trial aimed to assess the value of an information video (...) in this process. Patients scheduled to undergo colonoscopy were approached about 1 week before the procedure. All patients were given an information leaflet about colonoscopy, and completed a Spielberger state anxiety inventory (STAI) questionnaire to assess baseline anxiety. The patients were then randomly assigned to watch or not watch the information video. Immediately before colonoscopy, all patients completed a second anxiety questionnaire and a knowledge questionnaire. 198 patients were screened. 31

Lancet1999

480. Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications

Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications Casacalenda N, Boulenger J P Authors' objectives To assess the efficacy (...) of anxiolytics (alprazolam and azapirones) in major depressive disorder (MDD) and of antidepressants in generalized anxiety disorder (GAD), thereby exploiting the possible theoretical and clinical implications of this efficacy. Searching MEDLINE was searched from January 1980 to September 1997 for English language peer-reviewed articles using the following keywords: depressive disorders, anxiety disorders, generalized anxiety disorder, antidepressants, antianxiety agents, benzodiazepines and buspirone

DARE.1998